NewGenIvf Group Limited, an investment holding company, provides an assisted reproductive service that helps couples and individuals for fertility treatments in Thailand, Cambodia, Hong Kong, and Kyrgyzstan. The company provides a range of fertility treatment solutions, including in vitro fertilization (IVF), ICSI, embryo culture, hormonal blood tests, infectious diseases tests, chromosome screening, hysteroscopy, sperm analysis, sorting, washing, and freezing, and egg freezing. It also offers IVF treatment; surrogacy and ancillary caring services, and value-added services comprising nutrition guidance, psychological counselling, acupuncture, and translation interpreters to supplement the IVF treatment. The company provides its services through clinics. NewGenIvf Group Limited was founded in 2010 and is based in Bangkok, Thailand.…
NewGenIvf Group Limited Announces Pricing of $2.5 Million Underwritten Offering
NewGenIvf Group (NASDAQ: NIVF) is listed on Nasdaq, where its shares trade in USD. It belongs to the Medical Care Facilities industry, part of the Healthcare sector, and reports about 87 employees.
The shares were at 0.0269 USD on 20 November 2026, down 100.0% over 52 weeks. Its 52-week range is 0.0229 USD to 7413.12 USD: the price is 100.0% below the high and 17.5% above the low.
Its market capitalisation is 75.32K USD.
NewGenIvf Group reports return on equity of 37.1%, an operating margin of -238.2% and revenue down 4.7% year over year.
It holds more cash than debt, a net cash position of 2.78M USD. Its Piotroski F-score is 4 out of 9, an average reading of its financial health.
No upcoming events tracked.